• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

艰难梭菌感染的临床识别与诊断

Clinical recognition and diagnosis of Clostridium difficile infection.

作者信息

Bartlett John G, Gerding Dale N

机构信息

Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.

出版信息

Clin Infect Dis. 2008 Jan 15;46 Suppl 1:S12-8. doi: 10.1086/521863.

DOI:10.1086/521863
PMID:18177217
Abstract

Prompt and precise diagnosis is an important aspect of effective management of Clostridium difficile infection (CDI). CDI causes 15%-25% of all cases of antibiotic-associated diarrhea, the severity of which ranges from mild diarrhea to fulminant pseudomembranous colitis. Several factors, especially advanced age and hospitalization, should be considered in the diagnosis of CDI. In particular, nosocomial diarrhea arising >72 hours after admission among patients receiving antibiotics is highly likely to have resulted from CDI. Testing of stool for the presence of C. difficile toxin confirms the diagnosis of CDI. However, performance of an enzyme immunoassay is the usual method by which CDI is confirmed, but this test appears to be relatively insensitive, compared with the cell cytotoxicity assay and stool culture for toxigenic C. difficile on selective medium. Endoscopy and computed tomography are less sensitive than stool toxin assays but may be useful when immediate results are important or other confounding conditions rank high in the differential diagnosis. Often overlooked aspects of this diagnosis are high white blood cell counts (which are sometimes in the leukemoid range) and hypoalbuminemia.

摘要

及时准确的诊断是艰难梭菌感染(CDI)有效管理的一个重要方面。CDI导致所有抗生素相关性腹泻病例的15% - 25%,其严重程度从轻度腹泻到暴发性假膜性结肠炎不等。在CDI的诊断中应考虑几个因素,尤其是高龄和住院情况。特别是,接受抗生素治疗的患者入院72小时后出现的医院内腹泻很可能是由CDI引起的。检测粪便中是否存在艰难梭菌毒素可确诊CDI。然而,酶免疫测定是确诊CDI的常用方法,但与细胞毒性试验和在选择性培养基上对产毒艰难梭菌进行粪便培养相比,该试验似乎相对不敏感。内镜检查和计算机断层扫描比粪便毒素检测的敏感性低,但在需要即时结果或其他混淆情况在鉴别诊断中占比高时可能有用。该诊断中经常被忽视的方面是白细胞计数高(有时处于类白血病范围)和低白蛋白血症。

相似文献

1
Clinical recognition and diagnosis of Clostridium difficile infection.艰难梭菌感染的临床识别与诊断
Clin Infect Dis. 2008 Jan 15;46 Suppl 1:S12-8. doi: 10.1086/521863.
2
Lack of value of repeat stool testing for Clostridium difficile toxin.艰难梭菌毒素重复粪便检测的价值缺失
Am J Med. 2006 Apr;119(4):356.e7-8. doi: 10.1016/j.amjmed.2005.08.026.
3
[Six years evaluation of Clostridium difficile associated diarrhea].艰难梭菌相关性腹泻的六年评估
Mikrobiyol Bul. 2004 Jan-Apr;38(1-2):45-50.
4
[Investigation of the presence of Clostridium difficile in antibiotic associated diarrhea patients by culture and toxin detection methods].[采用培养和毒素检测方法调查抗生素相关性腹泻患者中艰难梭菌的存在情况]
Mikrobiyol Bul. 2007 Jan;41(1):29-37.
5
["Second look" at cytotoxin B of Clostridium difficile in the course of diarrhea associated with antibiotic therapy].艰难梭菌细胞毒素B在抗生素治疗相关腹泻病程中的“二次观察”
Pathol Biol (Paris). 1999 May;47(5):415-21.
6
Evaluation of four methods for detection of Clostridium difficile or C. difficile toxin: cytotoxin assay, culture, latex agglutination, and a new rapid immunoassay (C. difficile toxin A test).四种检测艰难梭菌或艰难梭菌毒素方法的评估:细胞毒素检测、培养、乳胶凝集试验以及一种新型快速免疫测定法(艰难梭菌毒素A检测)。
Z Gastroenterol. 1998 Feb;36(2):143-9.
7
[Clostridium difficile diarrhea: frequency of detection in a medical center in Buenos Aires, Argentina].[艰难梭菌腹泻:在阿根廷布宜诺斯艾利斯一家医疗中心的检出频率]
Rev Argent Microbiol. 2001 Apr-Jun;33(2):101-7.
8
Clinical and microbiological characteristics of community-onset Clostridium difficile infection in The Netherlands.荷兰社区获得性艰难梭菌感染的临床和微生物学特征。
Clin Microbiol Infect. 2009 Dec;15(12):1087-92. doi: 10.1111/j.1469-0691.2009.02853.x. Epub 2009 Jul 16.
9
[The frequency of Clostridium difficile toxin in neutropenic and non-neutropenic patients with antibiotic-associated diarrhea and analysis of the risk factors].[中性粒细胞减少和非中性粒细胞减少的抗生素相关性腹泻患者中艰难梭菌毒素的频率及危险因素分析]
Mikrobiyol Bul. 2008 Oct;42(4):573-83.
10
Clinical correlation of toxin and common antigen enzyme immunoassay testing in patients with Clostridium difficile disease.艰难梭菌病患者毒素与共同抗原酶免疫测定检测的临床相关性
Am J Gastroenterol. 2003 Jul;98(7):1569-72. doi: 10.1111/j.1572-0241.2003.07482.x.

引用本文的文献

1
-Cresol and : A Love-Hate Story Revealed by Raman Spectroscopy.-甲酚与:拉曼光谱揭示的爱恨情仇故事
Anal Chem. 2025 Aug 5;97(30):16583-16592. doi: 10.1021/acs.analchem.5c02927. Epub 2025 Jul 23.
2
Healthcare-Associated Infection: A Hospital-Based Retrospective Study in North Eastern Romania.医疗保健相关感染:罗马尼亚东北部一项基于医院的回顾性研究
Microorganisms. 2025 Jun 13;13(6):1377. doi: 10.3390/microorganisms13061377.
3
Association between statin administration and -induced enteritis: a retrospective analysis of the MIMIC-IV database.
他汀类药物给药与诱导性肠炎之间的关联:对MIMIC-IV数据库的回顾性分析。
Front Pharmacol. 2025 Feb 24;16:1550378. doi: 10.3389/fphar.2025.1550378. eCollection 2025.
4
C. difficile Infection Complicated by a Large Pleural Effusion.艰难梭菌感染并发大量胸腔积液
Cureus. 2025 Jan 15;17(1):e77460. doi: 10.7759/cureus.77460. eCollection 2025 Jan.
5
infection study models and prospectives for probing the microbe-host interface.用于探究微生物-宿主界面的感染研究模型及前景
J Bacteriol. 2025 Mar 20;207(3):e0040724. doi: 10.1128/jb.00407-24. Epub 2025 Feb 6.
6
Defining Fulminant Infections: Assessing the Utility of Hypotension as a Diagnostic Criterion.定义暴发性感染:评估低血压作为诊断标准的效用。
Open Forum Infect Dis. 2025 Jan 22;12(2):ofaf033. doi: 10.1093/ofid/ofaf033. eCollection 2025 Feb.
7
Comparison of Illumina and Oxford Nanopore sequencing data quality for Clostridioides difficile genome analysis and their application for epidemiological surveillance.用于艰难梭菌基因组分析的Illumina和牛津纳米孔测序数据质量比较及其在流行病学监测中的应用
BMC Genomics. 2025 Jan 30;26(1):92. doi: 10.1186/s12864-025-11267-9.
8
Global burden and trends of the infection-associated diseases from 1990 to 2021: an observational trend study.1990年至2021年感染相关疾病的全球负担及趋势:一项观察性趋势研究
Ann Med. 2025 Dec;57(1):2451762. doi: 10.1080/07853890.2025.2451762. Epub 2025 Jan 23.
9
Polysaccharide lyase PL3.3 possibly potentiating Clostridioides difficile clinical symptoms based on complete genome analysis of RT046/ST35 and RT012/ST54.基于RT046/ST35和RT012/ST54的全基因组分析,多糖裂解酶PL3.3可能会加重艰难梭菌的临床症状。
Int Microbiol. 2025 Jan 20. doi: 10.1007/s10123-025-00634-x.
10
Optimization of Microfluidics for Point-of-Care Blood Sensing.微流控技术在即时床边血液检测中的优化。
Biosensors (Basel). 2024 May 23;14(6):266. doi: 10.3390/bios14060266.